| Literature DB >> 12644313 |
Pio Conti1, Duraisamy Kempuraj, Kristiana Kandere, Mario Di Gioacchino, Renato C Barbacane, Maria L Castellani, Mario Felaco, William Boucher, Richard Letourneau, Theoharis C Theoharides.
Abstract
IL-10 has been previously called cytokine synthesis inhibiting factor, produced mostly by Th2 cells, macrophages and CD8+ cell clones. IL-10 is capable of inhibiting the synthesis of several cytokines from different cells, antigen or mitogen activated. IL-10 exerts its inhibition at the mRNA transcriptional and translational level. In addition, IL-10 is a co-stimulatory cytokine on activated T cells. For example, IL-10 inhibits NK cell activity, the production of Th1 cytokines, cytokines generated by peripheral blood mononuclear cells, and macrophage activity. On the other hand, IL-10 exerts immunostimulatory effects on B cells, cytotoxic T cell development and thymocytes. In mast cells derived from CD4+/CD133+ cells, IL-10 inhibits IL-6 and TNFalpha, and prostaglandin E(1) and E(2) induced by IL-6. Here, we report for the first time that IL-10 fails to inhibit tryptase and IL-6 from human mast cell-1 (HMC-1) and human umbilical cord blood-derived mast cells.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12644313 DOI: 10.1016/s0165-2478(03)00002-6
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685